Navigation Links
Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
Date:10/29/2009

WALTHAM, Mass., Oct. 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the global spinal nonfusion technology market will increase from approximately $400 million in 2008 to almost $2 billion by 2013. MRG's new Global Markets for Spinal Nonfusion Technologies 2009 report finds this market will be fueled by increased product approvals across the US, Europe, and Asia Pacific. Further adding to market growth will be the increase in average selling prices prompted by sales of these premium-priced nonfusion devices.

With the highest average selling prices of all three regions, the US contributed the majority of revenues to the global spinal nonfusion technology market in 2008, despite being a young market compared to Europe. The spinal nonfusion technology market is more developed in Europe, with a larger number of firms competing on price. Also, many of the devices lack full reimbursement in Europe, which contributes to lower pricing because many patients are unwilling to pay the full price of the nonfusion technology. Although the number of spinal nonfusion procedures performed in Europe was 80% of the volume observed in the US in 2008, price differences resulted in a total European market value of less than half of that in the US market.

New products, such as the M6-L lumbar artificial disc from Spinal Kinetics and the Barricaid annulus repair device from Intrinsic Therapeutics, will be released across the three regions and will lead to an intensification of marketing and training efforts on the part of manufacturers to promote the efficacy of spinal nonfusion treatments.

"As more surgeons become familiar with long-term clinical data and receive training on the techniques, an increasing number will adopt spinal nonfusion treatments in their practice and concerns regarding long-term efficacy will recede," says Deanna Vankessel, Analyst at MRG. "The release of new spinal nonfusion products will result in an influx of favorable clinical data and increased marketing of these new devices and technologies, fueling physician awareness and adoption."

MRG's Global Markets for Spinal Nonfusion Technologies 2009 report evaluates the performance of the spinal nonfusion technology market from 2007 to 2013 in the US, Europe and Asia Pacific. Each chapter includes an examination of artificial disc, dynamic stabilization, annulus repair, nuclear disc prosthesis, and facet arthroplasty procedures, as well as average selling prices and sales segmented by procedure. Chapters also contain a detailed account of the drivers and limiters that will impact the market and analysis of the leading competitors.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through syndicated reports, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com

SOURCE Millennium Research Group


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016   Click here ... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent ... a definitive agreement to acquire Valley Campus Pharmacy, ... ("TNH"), a leading specialty pharmacy that provides individualized ... California . In 2015, TNH generated approximately ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... 28, 2016   Acsis , a leading provider ... IT market research and advisory firm IDC has named ... MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor ... an assessment of the capabilities and business strategies of ... market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... Cosmetic dentistry is a fast-growing field as more patients are discovering the many different ... more about the options currently available to them and which ones might work for ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Reltok Nasal Products ... products for the head and neck/ear, nose and throat specialty, has added the KOTLER ... The KOTLER NASAL AIRWAY™ is a newly patented safety device secured by nasal ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, ... round of funding led by Eastside Partners, with participation from existing investor Martin ... customer base and accelerate its technology and product roadmap. , “Jvion ...
(Date:4/29/2016)... ... 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out of ... them second place for Tampa’s Best Places to Work. They were ranked in the ... great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We work ...
Breaking Medicine News(10 mins):